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INTRODUCTION 
Idiopathic Intracranial Hypertension (IIH) is defined as a clinical 
syndrome characterized by elevated intracranial pressure, in the absence of an 
identifiable pathology (hydrocephalus or space occupying lesion). 
It is characterized by the presence symptoms of raised intracranial 
pressure viz. head ache, vomiting, blurring of vision, pulsatile tinnitus, double 
vision, transient visual obscurations and signs of raised intracranial pressure 
(ICP) , like papilledema, VI th cranial nerve palsy, and investigations revealing 
increased cerebrospinal fluid (CSF) pressure with normal biochemical and 
cytologic analysis of CSF. 
This disease has been referred by various names since Quincke first 
described it as “meningitis serosa” as early as 1893.  Various terminologies 
used includes ‘otitic hydrocephalus” ‘Pseudotumour cerebri‘, ‘benign 
intracranial hypertension’. The term ‘ Benign intracranial hypertension’ which 
was in use for very  long time, since Foley introduced it in 1955,  was 
reconsidered as several reports of visual loss in these patients questioned the 
benign nature of this illness and hence it was renamed as ‘Idiopathic 
Intracranial  Hypertension’. 
IIH is considered as a disease of altered CSF flow dynamics resulting in 
increased CSF pressure. It is considered in those patients where a detailed 
neuro-imaging ruled out any structural cause for raised intracranial pressure. 
Incidence of disease is high among obese, young female patients. 
This study tries to analyse the various clinical presentation, 
investigations of IIH, with the outcome of illness. We also analyse the clinical 
presentation, investigations of IIH that can predict early surgical intervention in 
these patients. 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
 To study the clinical profile of the patients with Idiopathic Intracranial 
Hypertension 
 To study the co–relation between clinical presentation, CSF analysis, 
management and outcome of patients with Idiopathic Intracranial 
Hypertension 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITREATURE 
Historical background : 
 The first report of this condition was published by Heinrich Quincke 
(1893), a German physician who described it as ‘meningitis serosa’, 1 though 
Bouchat had described a similar disease prior to him in 1868 
 In 1904, Max Nonne, another German neurologist, identified cases that 
apparently looked like a cerebral tumour but which had more benign course of 
illness that made him coin the term ‘Pseudotumour Cerebri’. In 1930’s, Sir 
Charles Symonds, neurologist from England wrote a series of papers, about 
pediatric patients, who had raised intracranial pressure. He found an 
association between raised ICP and middle ear disease and described the 
disease as ‘Otitic Hydrocephalus’.2     
In the early and mid 20th century, serous meningitis and Pseudotumour 
cerebri were used extensively for those patients presenting with features of 
raised ICP with more benign course. Procedures like cerebral Pneumography, 
Ventriculography and Encepahalography permitted evaluation of live patients 
and further studies about this condition. Davidoff and Dyke in 1956 published 
15 cases with features of raised ICP but normal cerebral pneumography and all 
showed marked improvement with cranial decompression.3 The credits for 
postulating first diagnostic criteria goes to Walter  Dandy, who described 22 
cases who had raised ICP but no tumour.4  His criteria ‘ Dandy’s criteria’ was 
used for long to diagnose , cases of IIh , which was modified by Friedman and 
Jacobson in 2002.5 
 Foley in 1955 published a study in which he divided patients into two 
groups , one with ear disease and other with no known cause. He found that 
the cerebral ventricles were not dilated and hence regarded the term  
‘Hydrocephalus’ in appropriate he introduced the term ‘Beningn intracranial 
hypertension’ for non otitic cases.6 His patients were predominantly young, 
obese, females. Another important finding in his study was, ’there were variety 
of proposed numerous etiological agents, which were diverse that made one 
must suspect that none is a direct cause’. The term he introduced, remained 
for a very long time before the terminology ‘ Beningn ‘ was questioned by 
several case reports that reported visual loss. 
 It was in 1989, that Corbets and Thompson  proposed the name  
‘ Idiopathic Intracranial Hypertension’ a term which was suggested by Buchhiet 
as early as 1969. The late part of 20th century, saw many papers that 
postulated the mechanism of IIH, by Johnston (1973,1975),8,9 Fishman 
(1979,1984) Rottenberg et al (1980) and  Donaldson (1981).10 All of them 
favored, a primary pathology in CSF flow dynamics resulting in an imbalance 
between formation of CSF and its absorption leading to increase in CSF volume 
and raised ICP.  
DIAGNOSTIC CRITERIA : 
Though the disease has been described since 19th century, it was poorly 
defined. The general rule in the diagnosis of this disease was symptoms and 
signs of raised intracranial pressure with no hydrocephalus or space occupying 
lesion.  It was in 1937, Walter Dandy, American neuro surgeon proposed a 
diagnostic criteria for IIH.4 The criteria proposed by him stayed long and strong 
untill recently when Friedman and Jacobson in 2002 revised the criteria which 
are now popularly known as modified Dandy’s criteria.5  
Modified dandy’s criteria for Idiopathic Intracranial Hypertension5  
1). Patient presenting with symptoms of increased intracranial pressure 
2). Neurological examination is normal except for papilledema or sixth cranial 
nerve palsy. 
3). Neuro imaging does not show hydrocephalus or space occupying lesions 
and absence of abnormality of ventricular systems ( deformity, obstruction or 
displacement ) 
 4). CSF analysis shows elevated pressure (>250mm water) but normal bio 
chemical analysis 
5). Conscious and oriented patient 
6). Other causes of raised intracranial pressure are not present 
EPIDEMIOLOGY  
Incidence  
 The exact incidence of IIH in early days is not clearly known because of 
absence of uniform consensus in diagnosing the diseases and lack of advanced 
Neuro imaging. Furthermore the studies to evaluate the incidence of IIH is 
complicated by the fact that nearly half the patients landed up with 
ophthalmologist for headache and visual disturbance however later part of  
20th  century saw many series of cases which were reported and the incidence 
of IIH calculated. Incidence has been well documented after Friedman and 
Jacobson postulated modified Dandy criteria 
 Durcan et al in 1988  at Lowa USA, reported a incidence of 0.9 per 1 Lakh 
population.11 In  the same year he reported a incidence of 1.07 per 1 lakh 
population in Louisiana USA.29 In 1993 Radhakrishnan et al noted a incidence 
of 2.2/1,00,000 population in Libya12,15 
 In 2000 Yabe et al reported a incidence of  0.03/1,00,000 in Hokkaido 
Japan.13 Kaslar & Gadoth reported a incidence of 0.75/1,00,000 in Israel in 
2001.14 However studies on Incidence of IIH among Indian population are 
lacking. 
 
Gender and Age distribution  
IIH is more prevalent in women. Larger studies have reported female to male 
ratio from 4:3:1 to as high as 15:111, 12, 16, 17 
Studies Female : Male Age 
Durcan et al (1988) 4.3:1 Third Decade 
Radhakrishnan et al 15:1 28 
Craig et al (2001) 5.7:1 29 
Kesler et al (2000) 8:1 - 
Galvin&Van 
stavern(2004) 
9.3:1 35 
Mezael  & Saaldah 
(2005) 
11.5:1 36 
 
It is prevalent in younger age groups. In a study Durcan et al in 1988, 59% 
of patients were in third decade.11 Mean ages of onset in various studies are 
noted in the above table. 
  
Role of other factors in pathogenesis of IIH  
Obesity  
Dandy’s description of typical IIH patient was  ‘ A young obese female 
patient in her thirties came with complaints of throbbing headache with 
vomiting and double vision and her examination showing  papilledema and 
lateral rectus palsy while other systems were normal and her brain imaging 
unremarkable’.4  Foley’s study stated that 14 out of 60 pt were obese. But the 
prevalence of obesity in IIH is higher in other studies.6 Geer et al reported 20 
cases wherein all  were obese. Further weight gain appears to have increased 
the risk of IIH. Various studies quoting obesity      (BMI > 30) and IIH are  
 
Radhakrishnan et al 
Galvin et al 
Kesler & Gadoth 
Wall et al 
Benghazi et al 
 
71% 
88% 
91% 
94% 
98% 
 
The fact that recent gain in weight leading to IIH and weight reduction relieving 
symptoms further supports obesity as major risk factor.19 
Mechanism by which obesity leads to IIH. 
1. Raised intra abdominal pressure 20 
2. Release of pro inflammatory cytokinins by adipose tissue (Adipokine 
Leptin & Adiponectin)21 
Vitamin A 
 Vitamin A is known to affect the arachanoid villi structure in dural sinus 
leading to impaired absorption of CSF into systemic circulation.22 There are 
reports of occurence of IIH among patients who have been administered 
retinol containing compounds for dermatological and other condition. 
Jacobson et al (1999) showed significant higher serum retinol in 16 IIH 
patients.24 
Warnet (2002) and Tabassi (2005) showed elevation of CSF retinol levels 
in IIH patients compared with controls in their study. There are not enough 
studies to quote the percentage of prevalence of elevated retinol levels in IIH 
nor the role of retinol in pathophysiology of IIH.23 
 
Medications 
The role of drugs in IIH has been extensively studied. More common 
among them is tetracycline-class antibiotics,25 corticosteroid therapy,27 and 
oral contraceptive pills. Cric et al (1998) reported occurrence of IIH among 
patients taking tetracycline class antibiotics especially minocycline and 
doxycycline in 6 out of 34 patients.25 Patients were on chromic course of drugs 
for dermatological treatment. Similarly abrupt corticosteroid withdrawal 
resulted in a clinical syndrome similar to IIH.26 Further reintroduction of drug 
showed clinical improvement in these patients. The role of oral contraceptive 
pills in IIH has been widely debated. Whether OCP directly resulted in IIH or as 
a result of accompanying cerebral venous thrombosis is not clear. However 
Glueck et al in 2005 reported a series of IIH cases among 65 women who had 
normal cerebral venography, which strengthened the hypothesis of OCP 
directly causing IIH.  
 
 
 
 
 
Other medications associated with IIH. 
 Hormonal  
 Corticosteroid withdrawl 
 Levonorgestral 
 Danazol 
 Tamoxifen 
 Growth hormone 
 Anabolic steroids 
Antibiotics  
 Tertacycline and derivatives 
 Nalidixic acid/   
 Nitro furantoin 
NSAID’S 
 Indomethacin 
 Rofecoxib  
Vitamin A 
 Retinol 
 Retinoids  
Others  
 Lithium 
 Cimetidine 
                                                                              (Modified from Ball AK 2009) 
 
Pregnancy 
 The role pregnancy in pathogenesis of IIH has been traditionally studied. 
Grees(1965), reported eight patients with IIH in the first trimester of gestation. 
He also noted that duration of symptoms was shorter compared to non 
pregnant women, initially suggesting relationship between changes in estrogen 
levels to IIH. Later in 1984, Digre et al, after retrospective analysis noted that 
association of symptoms with age is a typical characteristic of an IIH patient 
rather than hormonal changes, a fact which was further supported by Durcan 
et al(1988) and Ireland et al(1990).28 
Other comorbid factors Prevalence Studies 
 
Polycystic ovary 
syndrome 
 
57% 
 
Glueck et al(2005)30 
39% Glueck et al(2003)31 
Sleep apnea syndrome 12% Marcus et al(2001) 
30% Lee et al (2002) 
4% Female 
24% Male 
Bruce et al (2009) 
Anaemia 
 
 
 
9% Female 
5% Male 
Bruce et al (2009) 
6% Mollan et al(2009) 
 
Systemic Hypertension 
14% 
28% 
32% 
Wall & George (2001) 
Galvin et al (2004) 
Ireland et al (1990) 
21% females 
24% males 
Bruce et al (2009) 
 
 
Other co-mortid factors associated with IIH. 
Diabetes mellitus, Migraine, SLE , Stroke, Hypoparathyroidism, Hepatitis 
A&E, Leukemia, Renal Transplant, Lysosome Storage Disorders.32 
CONDITION THAT MIMIC IIH (MICHEAL WALL 2010) 
 Reduced flow through arachanoid granulations  
1. Scarring from previous  inflammation (meningitis, SAH) 
 Obstruction to venous outflow  
1. Venous Sinus Thrombosis 
2. SVC Obstruction  
3. Glomus Tumour  
4. Elevated Right Heart Pressure  
 Endocrine Disorders 
1. Hypoparathyroidism  
2. Use of Growth hormone 
3. Steroid withdrawal  
4. Obesity  
5. Addison disease  
 Nutritional Disorders  
1. Hypervitaminsosis A 
2. Hyperalimentation in deprivation  
 AV malformation and dural shunts  
 Drugs  
o Anabolic Steroids  
o Chlordecone  
o Ketoprofen or indomethacin in Bartter syndrome  
o Thyroid replacement  
o Tetracycline and its derivatives  
o Amiodarone  
o Lithium carbonate  
o Nalidixic acid  
o Sulfa antibiotics  
o Oral contraceptives  
 Diseases  
o SCE, Via Venous Sinus Thrombosis  
o Sarcoidosis  
o Iron deficiency anemia 
o Hyperthyroidism  
o Menarche  
o Menstrual disturbances  
o Pregnancy  
PATHOPHYSIOLOGY OF IIH 
Even after 100 yrs since Quincke’s first description, the pathogenesis of 
IIH remains uncertain.33,34  Any Hypothesis postulated on pathophysiology of 
IIH should explain few intricacies of IIH namely absence  ventriculomegaly,  
Prelidiction to affect obese young females especially during child bearing age, 
reduced conductance to the outflow of CSF and absence of histological 
evidence of cerebral edema. 
IIH is basically a disease of altered CSF hemodynamics resulting in raised 
ICP. Alteration can be either increased CSF production or decreased CSF 
absorption.8 
CSF PRODUCTION & CIRCULATION  
 CSF is produced in choroid plexus of lateral ventricles by ependymal 
cells. There is a rich vasculature in the ventricles. The rate of CSF production is 
500ml in 24 hrs with a volume of 140ml at any point of time and CSF is 
renewed every 6-8 hrs. From the lateral ventricle, CSF enters into Third 
ventricle by foramen of Monro and then into fourth ventricle through cerebral 
aqueduct. Through median and lateral apertures it flows through 
cerbellomedullary cistern into spinal cord  and over cerebral hemispheres.10 
  
EXCESSIVE SECRETION  
 Quincke in 1893 suggested that there could be hyper secretion of CSF 
leading to raised ICP in IIH.1 However later studies with isotope cisternognaphy 
proved it wrong.  
 Several studies postulated that there is no difference in CSF production 
between IIH patients and controls and in fact it is less. Hence the hypothesis of 
increased CSF production in pathogenesis of IIH faded way.3  
CEREBRAL EDEMA  
 Earlier study reported diffuse brain edema in IIH as demonstrated in 
postmortem findings. Later studies using various MRI sequences had showed 
no significant brain edema. Absence of other clinical features of edema, 
preservation of neurological function and  clinical course all made cerebral 
edema unlikely in IIH.35,36  
REDUCED CSF ABSORPTION  
 The most accepted concepts in pathogenesis of IIH is the reduced CSF 
absorption. The circulating CSF are absorbed into systemic circulation by 
arachanoid villi and granulations in dural venous sinuses. An earlier study 
demonstrated the increased resistance to CSF drainage by intrathecal saline 
infusion test. In 1974, Johnson And Paterson using isotope Cisternognaphy 
demonstrated a delay in circulation of CSF and also holding up in sub arachnoid 
space.8  A similar disturbed CSF flow pattern was demosntrated by orefice at el 
in 1992 in 6 IIH patients who were obese. Gjerrris et all in 1985 used lumbo 
lumbar perfusion methods to measure CSF outflow resistance, he noticed 
abnormally low conductance in all of his 14 IIH patients.   The following 
changes were noted in CSF flow Dynamics.37 
1. Increased CSF pressure 
2. Reduced conductance to the CSF Outflow 
3. Difference in pressure across various CSF outflow pathways. 
Dysfunction of arachanoid villi accounted for the reduced CSF outflow 
conductance. Whereas in patients who has normal or slightly reduced outflow 
conductance, high pressure in sagital venous sinuses were recorded. The 
increase in CSF Pressure is however not associated with consequent ventricular 
dilatation. This was probably explained by Lenine et all in 2000. In which he 
suggested that increased CSF pressure is uniformly distributed in ventricles and 
subarachnoid space and  a  new equilibrium is reached which prevents 
ventricular dilation. The conclusion of his study stated that there is raised ICP 
due to abnormal absorption of CSF into blood stream by abnormalities in 
archanoid villi 
  
IIH and cerebral venous system 
Whether the increased CSF Pressure in IIH is primary or Secondary to high 
Pressure in venous sinuses is debatable. In earlier days raised ICP due to 
venous sinus thrombosis were considered as IIH but later criteria by Dandy 
clearly differentiates Raised ICP Due to venous sinus thrombosis from IIH.38 
However the raised venous pressure due to anatomical narrowing or 
generalised venous hypertension, as a cause of IIH is debatable. Farb et al  in 
2003 did a extensive study among 29 IIH Patients with MRV in which he found 
27 of them had substantial venous sinus stenosis leading to anatomic 
variability of dural venous system. King et al (2005) demonstrated raised 
pressure, in absence of thrombosis within the superior sagittal and transverse 
sinuses. Whether raised venous pressure is due to IIH or a cause of IIH is clearly 
not known. 
CLINICAL FEATURES 
Symptoms 
IIH patients presents with variety of clinical symptoms and signs. Most 
common symptom is headache. Other common presenting symptoms include 
transient obscuration of vision, pulsatile tinnitus, photopsia, and retrobular 
pain. Less common features are diplopia and visual loss.32 In a prospective 
study of 50 patients by Wall et al in 1991, the prevalence of various symptoms 
are as follows: 39 
Head ache 94% 
Transient visual obscuration 68% 
Tinnitus  58% 
Photopsia 54% 
Retrobular pain 44% 
Diplopia  38% 
Visual loss 30% 
 
Headache: 
Headache is the most common presenting feature in majority of IIH 
patients. The features of IIH headache are daily severe headache, pulsatile 
quality which is markedly different in severity, intensity and frequency 
compared to previous headaches.40 It may awaken patient from sleep or is 
worse in mornings when patient gets up from sleep, often reported as worst 
headache ever.41 It is commonly associated with nausea and sometimes 
vomiting. It frequently co- exists with other head syndromes like rebound 
headache from analgesic or caffeine . Neck and back pain are also prominent 
features.39 
Transient visual obscurations 
Transient visual obscurations are common among IIH although it is not 
specific for IIH. It is often a presenting symptom. In study of IIH patients by 
Push JA (1980), 70% of patients complained of visual obscurations typically 
lasting for seconds. The pathogenesis of obscuration is probably due to disc 
edema leading to transient optic nerve head ischemia. 
Pulsatile tinnitus  
In study by Givseffi et al (1991)  60% of IIH patients presented with 
tinnitus or intracranial ringing noises described as whooshing or roaring in the 
ear. The tinnitus was pulsatile with correlation to heart beat. It can be 
unilateral or bilateral. Tinnitus disappears or decreases after lumbar puncture 
or jugular venous compression. It is attributed to the transmission of 
intensified vascular pulsations to the venous sinus wall through high pressure 
CSF, converting laminar to turbulent flow.32 Fishman 1992 postulated that 
tinnitus may be due to transmission of pressure sensation to endolymph of 
labyrinth through endolympatic duct. Hearing loss have also been described in 
IIH by Sisman (1985) and  Dormati et al (1995). 
Visual loss 
Visual loss is not a usual symptom of IIH but if present is a worrisome 
sign. Patients usually report blurred vision or a dark spot in vision, which is 
probably due to enlargement of blind spot due to papilledema. Some patients 
have complained of tunnel like vision. However complete visual loss or 
blindness is seen only in severe cases of IIH. The temporal profile also varies; 
central visual loss early in the course of illness is a poor prognostic sign.42 
Patients usually presents with black hole in vision due to papilledema and 
enlargement of blind spot. In early stages the vision remains near normal. 
Vision loss is expected when the condition is long standing and there is retinal 
detachment or optic disc edema extends up to macula. Routine Snellen’s chart 
testing can be insensitive to visual loss, which may be picked up only with 
perimetry. Snellen’s acuity testing is also insensitive to worsening of 
papilledema. Contrast sensitivity is an early and a sensitive indicator of optic 
nerve dysfunction in IIH. The mechanism of visual loss in IIH has been 
extensively studied. The field defects in IIH seemed to be optic Disc related. 
The analysis of visual field defect and histological changes in IIH, points to optic 
disc (optic nerve head )  as the site of damage IIH. 
Hayreh SS extensively studied the mechanism of visual loss in IIH. He 
postulated that there are two major mechanism for damage to optic disc in IIH 
which are43,48 
1. Disruption of Axonal transport 
2. Intracranial optic nerve ischemia 
Increased CSF pressure, low intraocular pressure and a marked decrease 
in systemic blood pressure leads to stasis of axoplasmic flow. The stasis of 
axoplasmic flow, intra axonal swelling leading to intra neuronal optic nerve 
ischemia.48 
Visual loss which is mild or absent on early course of illness, rapidly 
progress as the intra neuronal optic nerve ischemia ensues.50 
Double vision 
Double vision or diplopia is noted in 40-60% of IIH patients and one third 
report it as a presenting complaint. Diplopia is usually binocular with images 
separated horizontally. It is due to unilateral or bilateral abducens nerve palsy. 
There are rare instance of monocular diplopia reported which occurs as a 
result of macular edema or exudates due to severe papilledema. Binocular 
diplopia usually resolves as treatment is started and as ICP becomes normal.39 
Other symptoms 
Other minor symptoms, that IIH patient may have at presentation 
includes, neck pain, shoulder arthralgia, facial palsy , radicular pain, neck 
shiftness, parasthesias and ataxia. Psychological manifestation includes , 
depression and anxiety. Minor cognitive symptoms like impaired concentration 
and memory have also been noted.32 
SIGNS 
Papilledema  
Papilledema is a hallmark finding in IIH  and the diagnosis of IIH has to be 
reconsidered in absence of papilledema. In IIH papilledema is usually bilateral 
and asymmetrical but can occur unilaterally.45 It is usually evident by direct 
ophthalmoscopy but can be missed in earlier stages of illness during which, it is 
evident only by indirect  ophthalmoscopy.43 Stereoscopic fundus photography 
and fluorescein angiography may be used to detect subtle papilledema in 
earlier stages. Although several studies have shown a definite association 
between visual loss and degree of papilledema, the appearance of optic disc 
does not predict visual outcome in IIH patient.44 Apart from vascular leakage, 
exudation, axon swelling and degeneration contributes to papilledema in 
raised ICP.43,57 Since papilledema is an important sign for diagnosing, assessing 
severity & grading and influence of treatment it is necessary to have a 
standard rating scale. The grading of papilledema is done using  Frisen scale, 
which grades papilledema from Stage 0 to stage 5 (table). 
Frisen scale46   
 
 It is important to exclude other conditions that mimic Papilledema 
(Pseudopapilledema). Conditions that mimics include the optic disc, optic disc 
drusen or myelinted nerve fiber layer. But these conditions can be easily 
differentiated by stereoscopic fundus examination. Pitfalls include absence of 
definitive papilledema in very early course of disease or when there is raised 
ICP in a pre – existing optic atrophy. In cases of relapse gliosis of retinal nerve 
fiber layer may mask the development of papilledema. 
Ocular Motility Disturbances  
Wall et al (1991) reported ocular disturbances in the form of diplopia, 
mainly horizontal in one third of IIH patients and common finding was sixth 
nerve palsy in 10-20%. Both unilateral and bilateral palsies has been noted. IIH 
typically presents with binocular, horizontal diplopia with esotropia. Other 
uncommon forms include vertical diplopia due to skew deviation or IV nerve 
palsy, global opthalmoparesis and LMN type of VII nerve palsies.47 The 
common mechanism seems to be the acute bend that these CN make that 
makes them susceptible to raised ICP. The Disturbances resolves as the 
Intracranial pressure is lowered. In general, ocular motor palsies other than VI 
should be viewed with suspicion and other causes should be actively 
evaluated. 
INVESTIGATIONS  
Apart from routine investigations to rule out secondary causes of raised 
ICP, there three important modalities to be tested for all patients suspected for 
all patients suspected to have IIH. 
1. Visual acuity & optic nerve function test 
2. Neuro imaging – especially MRI 
3. CSF examination 
Visual acuity testing is done by Snellen’s chart though it carries poor 
sensitivity it is done first followed by perimetry. 
Perimetry   
Visual field defects occur in almost all patients with IIH. In a prospective 
study of 50 IIH patients done by Wall et al in 1991, showed that field defects 
were found in 96% of patients when Goldman perimetry is used and 92% in 
automated perimetry.39 More than 30% of patients, who had mild visual loss, 
did not even notice visual disturbances. Commonest finding in perimetry 
includes enlargement of blind spot, inferior nasal step defect, loss of peripheral 
nasal field of vision followed by arcuate defects.49,57 At later stages there is 
gradual depression of entire field which more pronounced peripherally. With 
treatment there is significant improvement in field defect as evaluated by 
perimetry in almost 50% of patients.52 
Neuroimaging: 
A routine plain CT brain in unremarkable in patients with IIH. In fact a 
normal Imaging forms a criteria for the diagnosis of IIH. However MR imaging 
of brain may reveal empty Sella, dilated optic nerve sheath especially dilation 
of perineuronal sub archanoid space, protrusion of optic papilla into posterior 
globe resulting in flattening sclera may be seen.53 MR venogram, an elliptic 
centric 3-D, gadolinium enhanced MRV, may reveal venous sinus stenosis, 
most commonly transverse sinus. Transverse sinus stenosis reverses with LP or 
Shunting. Raised ICP in uncommon patients (Men, children & slim women) 
should be evaluated in detail to find an underlying cause.38,54  
CSF Examination  
CSF Examination is crucial in diagnosis IIH and diagnosis should not be 
presumptively made without it. The LP should demonstrate a elevated CSF 
pressure and normal CSF Contents.55,56 
 
Significant CSF pressure values 
>250mm in adults 
>280mm in children 
>250mm in children (if not sedated /obese) 
201-249 non diagnostic. 
 
If CSF pressure fluctuates or remains normal but there is strong clinical 
suspicion of IIH, then LP is repeated. Alternatively CSF outflow pressure or R 
out can be calculated by bolus injection method.37  
The Pressure must be measured in lateral decubitus position with legs 
relaxed. A spinal needle of 18-20 Gauge is prefered. The Pressures recorded in 
sitting / Prone posture can be inaccurate. The base of manometer should be at 
the revel of right atrium. The CSF should be sent for bio chemical, micro 
biological analysis and cytology.8 
Treatment : 
The Treatment for IIH is Multi centric , with diet and life style changes to 
reduce weight, Medications, like carbonic anhydrase inhibitors 
(acetozolamide), diureties and analegesics and therapeutic LP and CSF 
drainage and in refractory patients surgical intervention.9 
Diet and Weight loss: 
Weight loss is an important factor in producing remission of IIH. 
Sugerman et al (1995) in a study noted that 8 morbid obese females who had 
IIH  had undergone gastric surgery and achieved weight loss of mean 55kg had 
resolution of papilledema and clinical improvement.20 Kupersmith et all in 
1998, made a retrospective study of 58 female IIH patients who showed 
improvement after losing 2.5 kg over 3 months period; various studies 
demonstrated a positive correlation between weight loss and improvement in 
symptoms.58 
Medications  
The Drug that has been extensively studied in management of IIH is 
Acetazolamide, which is a carbonic anhydrase inhibitor. Carbonic anhydrase is 
present in choroid plexus of ventricles and plays a major role in secretion of 
CSF. A study by Tosmark et al in 1988 showed positive improvement in 
symptoms in 75% of IIH patients. The effective dose is around 1-4gm/day given 
as divided doses as three to four times a day. It is sulfonamide drug. Adverse 
reactions includes rashes, aplastic anemia, renal calculus and parasthesia and 
unpleasant taste with carbonated beverages. Methazloamide another 
Sulfonamide drug with similar action may be tired if patient cannot tolerate 
acetazolamide.59 
Furosemide another loop diuretic may be used, it also reduces CSF 
secretion from Choroid plexus.60 Other diuretics (Thiazide, Spironolactone & 
Triamterene) have been tried with little success and are mainly reserved for 
those patients who cannot tolerate acetazolamide corticosteroids has been 
studied extensively in IIH.27 It shows rapid decrease of ICP and improvement of 
symptoms, but adverse effects like weight gain, fluid retention, rebound 
hypertension on tapering makes its use limited. At present corticosteroids are 
used for those patients who require  rapid reduction of ICP like visual loss and 
Surgery (Liu Gt et al 1994). Headache is symptomatically managed with 
NSAID’S, TCA and sodium valproate. Topiramate is another promising drug 
used for headache prevention and also produces weight loss. In a study of 24 
IIH patients using Topinamate 15 had weight loss and 10 had improvement a 
headache. Indomethacin, triptans and dihydroergotamine has also been 
studied  
Repeated Lumbar Puncture  
Repeated LP has been tried in those patients who were   refractory to 
medical treatment and not ideal candidates for surgery and in patients who 
are planning surgery for symptomatic relief. The effect is short lasting and 
unpredictable duration and more useful in infrequent exacerbations. Relief of 
headache and minimal improvement in vision has been noted.9 
SURGICAL TREATMENT  
The indications for surgery in IIH are loss of vision or worsening of vision 
that is attributable to the papilledema in IIH. Earlier subtemporal or subocipital 
decompression were used in patients with loss of vision and showed long term 
success, but these procedures are not frequently used now because of its 
complications line seizures, otorrhea and sub dural hematoma.58  The 
Procedures widely used now are optic nerve sheath fenestration (ONSF) and 
CSF shunt procedures. 
ONSF – It involves fenestration of optic nerve sheath or creating a 
window in edematous optic nerve sheath. It is considered as a treatment of 
choice in patients with decreasing vision. Mechanism by which it prevents 
visual loss is still not clear but proposed hypothesis included filtering 
mechanism, scarring of peneurium and shifting of pressure gradient from 
lamina cribrosa to myelinated segment of optic nerve. It increases the blood 
flow to optic nerve, decreases ICP thereby improving vision and decreasing 
headache.64  
Some facts about ONSF  
1. Procedure done unilaterally improves vision bilaterally  
2. More useful for acute papilledema  
3. Not useful in chronic papilledema or once papilledema is resolved  
4. Sometimes requires revision  
5. Complications includes failure, ischemic optic neuropathy 
transient diplopia and blindness  
CSF SHUNTING  
 Lumbo peritoneal and ventriculo peritoneal shunting are the commonest 
CSF shutting procedures. Lumbo peritoneal shunting is more preferred over 
ventirculo peritoneal shunting. Studies showed that shunting procedure show 
improvement of symptoms in 82% of patients and complete resolution in 29% 
there was also dramatic improvement in visual field. However both shunting 
procedures are characterized by high failure rate >50% which requires revision 
of shunt and other complications, like CSF leak, abdomen pain, infection, hind 
brain herniation, headache, displacement of catheter also necessitated 
revision procedures.63       
OTHER SURGICAL PROCEDURES  
Venous sinus stenting 
The studies showing the role of transverse sinus stenosis in pathogenesis 
of IIH had created interest in using endovascular stenting for the treatment of 
IIH. Various case series on this procedure shows varying results.62 Through 
there is improvement in clinical symptoms, there is high mortality due to 
complications of procedure which includes sub dural and epidural hematoma, 
anaphylaxis , hearing loss and death. Hence this procedure is preserved for 
severe or fulminant IIH and in those patients who have tried all other surgical 
methods.58 
BARIATRIC SURGERY  
 The role of bariatric surgery in management of IIH was studied by 
sugerman et all (1995) in which he showed positive improvements in 8 morbid 
obese female IIH patients. However it plays a role in long term management of 
IIH, rather than acute relief of symptoms and it has no role in improvement of 
visual function or prevention of visual loss.61 
 
 
  
 
  
    
Materials and Methods 
 The study was undertaken at The Institute of Neurology, Madras 
Medical College And Rajiv Gandhi Government General Hospital, Chennai 
between December 2012 and December 2013. All patients who presented with 
headache with or without vision disturbance and who fulfilled modified 
Dandy’s criteria for IIH  were taken into study after obtaining consent. All 
patients who had structural lesions (SOL) in CT or MRI were excluded from 
study. A detailed clinical examination was done and findings were entered into 
a proforma (see annexure). Patient underwent imaging studies, MRI brain and 
after excluding SOL or hydrocephalus, lumbar puncture was done and CSF 
analysis done. CSF pressure study was done by bolus injection method, 
advocated by Marmarou and improvised at the Institute Of Neurology (MIN 
method), after obtaining  prior, written consent from patients. 
CSF Pressure Study  
 Procedure 
 Patient is positioned in right lateral decubitus position and under sterile 
aseptic precautions, lumbar puncture is performed with 20 G needle and the 
needle is connected to saline manometer through a 3 way adopter without 
letting out any CSF. The patient is allowed to relax, extend lower limits and 
neck, lying comfortably in right lateral position, and opening pressure Po is 
noted after saline column stabilizes. 
 A known volume of saline rV, usually 5ml is injected into subarachnoid 
space at the rate of 1ml/second through 3 way port. The peak pressure Pp, 
reached after the bolus injection is noted. The saline column falls gradually 
after reaching one peak. After a certain time, t (in min), The pressure recording 
in the manometer, Pt is noted. 
 The CSF outflow resistance is calculated by the two step Marmarou’s 
formula: 
Step 1:    Calculation of the pressure – volume index (PVI). 
      PVI = rV/log (Pp/Po) 
Step 2: Calculation of resistance to outflow of CSF (Rout) 
 Rout =  
 This value is divided by 1.36 to express in mmHg/ml/min. about 25 to 30 
ml of therapeutic drainage of CSF was done in each case. The procedure was 
uneventful in all cases, and the patients tolerated procedure  well. The details 
of the patient and observations were recorded in a detailed proforma, 
tabulated. 
ANALYSIS OF RESULTS 
 Forty patients with features of IIH were treated during December 2012- 
December 2013 were included in the study. 
Age: 
Age group  No of patients 
16-20 1 
21-25 6 
26-30 14 
31-35 4 
36-40 12 
41-45 3 
 
Sex : 
MALE FEMALE 
5 35 
 
Body mass index: 
 BMI of patients were calculated using formula 
 BMI =  weight in Kg/(Height in m)2 
Patients were classified according BMI as 
 
BMI NO.OF.PATIENTS 
Normal                         1 
Over weight          11 
OBESE 28 
 
 
 
 
BMI                                        CATEGORY 
< 19                                        under weight 
19-24.9                                 normal weight  
25-29.9                                 overweight 
> 30                                       obesity 
Class I – 30-34.9 
          II – 35-39.9 
          III - > 40                                           ( NIH 2000) 
Symptoms : 
 Symptoms like head ache, diplopia, tinnitus were analyzed among 40 
patients, head ache was present in all 40 patients and constituted the major 
symptoms for which patients sought neurological opinion. The head ache was 
holocranial, compressing to stabbing type and was pulsatile in majority of 
them. It was associated with vomitting and nausea in half of the patients.  
 Diplopia was present in 32 patients and in 13 Patients diplopia was a 
presenting symptom. 29 patients mainly complained of blurring of vision but 
on probing they were noted to have diplopia. All of them complained of 
disturbances in distant vision . 
 15 patients complained of ringing sound in ears, which was unilateral in 
8 patients and bilateral in remaining . 6 patients complained of hearing 
intracranial noises. 
Vision disturbances in the form of visual obscurations were complained 
by 23 patients. Many of them complained as transient darkness and remaining 
as blurring of margins of images lasting as short as 5 sec to 2 min. there was 
however no complete loss of vision reported by any of them. Visual 
obscuration appeared prominent when the headache intensity increases. 
 
Symptoms No of patients 
Headache 
Diplopia 
Tinitus 
Visual obscuration 
40 
32 
15 
23 
Clinical findings 
All Patients Underwent Neuro Opthalmological evaluation which 
includes examination of Fundus by Neuro ophthalmologist and visual field 
charting by  perimetry . Fundus examination revealed Papilledema in all 
patients with bilateral Papilledema in 28 patients, while 8 patients had 
Papilledema only in right and 4 only in left. Even in Patients with unilateral 
papilledema, hyperemia of disc on opposite side was noted. Visual field 
examination revealed enlargement of blind spot corresponding to finding of 
Papilledema. 
 Among 40 patients,32 had evidence of lateral rectus palsy, of which 22 
had right, 10 patients had left and 4 patients had bilateral lateral rectus palsy. 
However visual acuity measured using Snellen’s  chart was normal in 24 
patients, while remaining had visual acnity ranging from 6/24-6/60. Worst 
vision recorded was 5/60 in a patient who subsequently underwent surgery for 
detoriation of vision. 
Papilledema: 
     Bilateral -                  28 
     Right alone –             8 
     Left alone -                 4 
 
Lateral Rectus Palsy 
Bilateral –             4 
Right alone –       22 
Left alone -            6 
 
Associated conditions : 
 Three of our patients were pregnant during our study, one in first 
trimester and 2 in second trimester. All the 3 had history of consumption of 
oral contraceptives prior and also had headache prior to conception. One 
patient was detected to have IIH prior to pregnancy and was on 
Acetazolamide, while other 2 patients were detected only after conception  
 Ten patients were on chronic drug use. Seven had oral contraceptive 
pills and 3 steroids. Among seven, 4 had taken them regularly during preceding 
1 year. Among 3 patients who had taken steroids 2 had taken for nephritic 
syndrome 10 years prior to onset but discontinued and was not on drugs now. 
One patient had taken steroids for bronchial asthma through all routes, 
inhalation, oral and systemic. 
Investigations  
 All patients were evaluated with routine biochemical investigations 
including sugar, renal and liver parameter. MRI brain was taken with special 
focus over orbital cuts MRI changes including perioptic nerve sheath widening, 
empty sella, kinking of optic nerve, flattening of posterior globe of sclera were 
noted. MRI was also screened for SOL and hydrocephalus. 
MRI FINDINGS Alone  1+2 1+2+3 Total 
1) Empty Sella 10 4 10 24 
2) Peri  optic nerve 
sheath widening  
10 - 10 20 
3) Flattening of 
posterior globe 
- - 10 10 
4) Transverse sinus 
Stenosis 
- 4 4 4 
5) Normal    10 
  
CSF analysis 
  All 40 patients underwent lumbar puncture and CSF analysis including 
biochemical, microbiological, cytology and pressure studies were done after 
obtaining written consent and under strict aseptic precautions. 
 All patients had normal biochemical values (sugar, protein, sodium + 
chloride). All of them were acellular. Opening pressure and Rout as described 
earlier were done, CSF Opening pressure greater than 250 mm of CSF was 
taken as abnormal or high and CSF outflow pressure calculated greater than 
9.6mm hg was considered raised . 
 
   
 
 
 
All 40 patients were started T. Acetazolamide at 250- twice a day and escalated 
if necessary. Apart from Acetazolamide, Frusemide, loop diuretics was started 
for 16 patients in addition to Acetazolamide. 
Elevated opening pressure  26 
Elevated CSF Rout  28 
Normal opening pressure with elevated 
Rout 
13 
Both normal 1 
 Patients symptoms were re-analyzed after 3 months after starting 
medications. 
Symptomatic       -26 
Asymptomatic     – 8 
Not reported        -6 
  
Among 26 symptomatic patients, repeat lumbar puncture and 
therapeutic CSF drainage for persistence of symptoms were done in 7 patients. 
Among 26 symptomatic patients, 7 were taken up for surgery, all had 
worsening of vision, enlargement of blind spot and persistence of headache. 
All underwent lumbo peritoneal stunt. Surgery was uneventfull 
 
 
 
 
 
 
 
 
STATISTICAL ANALYSIS 
All result were tabulated and statistically analyzed using SPSS 17.0 
Software.  All the Symptoms and BMI were analyzed with outcome after 
3months and for surgery. None of them had statistically significant co-relation 
with the Outcome. 
  CSF Pressures, opening pressure and Rout had statistically significant Co- 
relation with outcome (Opening Pressure P = 0.009 and Rout P = 0.037).  
Elevated opening Pressure and CSF Rout Considerably affects outcome and 
patent with elevated values remain symptomatic at the end 3 months of 
treatment with adequate dose of acetazolamide. 
 
Correlation between CSF - Opening Pressure and Symptoms After 3 Months 
 
 
    
Symptoms After 3 Months 
Total 
Presen
t Absent 
Not 
reported 
CSF - 
Opening 
Pressure 
Normal Count 9 0 5 14 
% within 
CSF - 
Opening 
Pressure 
64.3% .0% 35.7% 100.0% 
% within 
Symptoms 
After 3 
Months 
32.1% .0% 83.3% 35.0% 
Abnormal Count 19 6 1 26 
% within 
CSF - 
Opening 
73.1% 23.1% 3.8% 100.0% 
Pressure 
% within 
Symptoms 
After 3 
Months 
67.9% 100.0% 16.7% 65.0% 
Total Count 28 6 6 40 
% within 
CSF - 
Opening 
Pressure 
70.0% 15.0% 15.0% 100.0% 
% within 
Symptoms 
After 3 
Months 
100.0% 100.0% 100.0% 100.0% 
 
 
 Chi-Square Tests 
 
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson Chi-
Square 
9.492(a) 2 .009 
Likelihood Ratio 11.224 2 .004 
Linear-by-Linear 
Association 
2.679 1 .102 
N of Valid Cases 40     
 
 
 
a  4 cells (66.7%) have expected count less than 5. The minimum expected 
count is 2.10. 
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Correlation between CSF - Rout and  Symptoms After 3 Months 
 
 
    
Symptoms After 3 Months 
Total Present Absent 
Not 
reported 
CSF – 
Rout 
Normal Count 14 1 0 15 
% within 
CSF – 
Rout 
93.3% 6.7% .0% 100.0% 
% within 
Symptoms 
After 3 
Months 
50.0% 16.7% .0% 37.5% 
Raised Count 14 5 6 25 
% within 
CSF – 
Rout 
56.0% 20.0% 24.0% 100.0% 
% within 
Symptoms 
After 3 
Months 
50.0% 83.3% 100.0% 62.5% 
Total Count 28 6 6 40 
% within 
CSF – 
Rout 
70.0% 15.0% 15.0% 100.0% 
% within 
Symptoms 
After 3 
Months 
100.0% 100.0% 100.0% 100.0% 
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 Chi-Square Tests 
 
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson Chi-
Square 
6.578(a
) 
2 .037 
Likelihood 
Ratio 
8.702 2 .013 
Linear-by-
Linear 
Association 
6.280 1 .012 
N of Valid Cases 40     
 
a  4 cells (66.7%) have expected count less than 5. The minimum expected 
count is 2.25. 
 
Elevated CSF opening pressure, shows a statistically significant 
correlation (p<0.050 Significant at 5 Level) on deciding the need for surgery in 
IIH patients.  However CSF Rout does not show significant co- relation in 
predicting the need for surgery. 
 
Correlation between CSF - Opening Pressure and  Surgery 
 
 Crosstab 
 
    
Surgery 
Total Present Absent 
CSF - 
Opening 
Pressure 
Normal Count 0 14 14 
% within 
CSF - 
Opening 
Pressure 
.0% 100.0% 100.0% 
% within 
Surgery 
.0% 42.4% 35.0% 
Abnormal Count 7 19 26 
% within 
CSF - 
Opening 
Pressure 
26.9% 73.1% 100.0% 
% within 
Surgery 
100.0% 57.6% 65.0% 
Total Count 7 33 40 
% within 
CSF - 
Opening 
Pressure 
17.5% 82.5% 100.0% 
% within 
Surgery 
100.0% 100.0% 100.0% 
 
 
  
 Chi-Square Tests 
 
  Value Df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 
4.569(b
) 
1 .033     
Continuity 
Correction(a) 
2.894 1 .089     
Likelihood 
Ratio 
6.809 1 .009     
Fisher's Exact 
Test 
      .075 .035 
Linear-by-
Linear 
Association 
4.455 1 .035     
N of Valid Cases 40         
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected 
count is 2.45. 
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Correlation between CSF - Rout  and Surgery 
 
    
Surgery 
Total Present Absent 
CSF – Rout Normal Count 3 12 15 
% within 
CSF – Rout 
20.0% 80.0% 100.0% 
% within 
Surgery 
42.9% 36.4% 37.5% 
Raised Count 4 21 25 
% within 
CSF – Rout 
16.0% 84.0% 100.0% 
% within 
Surgery 
57.1% 63.6% 62.5% 
Total Count 7 33 40 
% within 
CSF – Rout 
17.5% 82.5% 100.0% 
% within 
Surgery 
100.0% 100.0% 100.0% 
 
 Chi-Square Tests 
  Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 
.104(b) 1 .747     
Continuity 
Correction(a) 
.000 1 1.000     
Likelihood 
Ratio 
.103 1 .749     
Fisher's Exact 
Test 
      1.000 .533 
Linear-by-
Linear 
Association 
.101 1 .750     
N of Valid Cases 40         
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected 
count is 2.63. 
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DISCUSSION 
In our study, we examined the age, BMI, clinical Presentation, Investigations 
(Imaging  & CSF Pressures) and outcome of 40 Patients with IIH. 
Demographic features 
Age - The Youngest age in our study is 18 and the oldest is 42 years old, with 
mean age of 31.7 years.  This correlates well with study by Wall & George 
(1991) in which mean age was 31 years.   
Male : Female ratio was 1:7, This is slightly lower than study by Wall and 
George  (1991) which had a prevalence of 1:12 and Bruce et al (2009) which 
had 1:10.1. Keslare et al reported a similar prevalence 1:8 in 2000. 
Analysis of BMI showed only I patient had normal weight, 11 (27%) patients 
were overweight (BMI 25-29.9) and 28 (70%) were obese (BMI >30). (NIH 
2000).  Studies done in western population has greater incidence of obesity 
(92% Ak ball 2009).  Among IIH patient Wall and George reported 47 out of 50 
patients as obese.  
Symptoms       
Headache is present in all 40 Patients in our study, Headache has a 
quality of raised ICP in all of them, and majority experience vomiting and 
nausea at least once during this course of illness.  Various studies (Wall and 
George 1991, Radhakrishnan et al 1993, kesler  et al) all noted a similar 
prevalence of headache among IIH patients (80-98%) 
Diplopia was noted in 32 (80%)of our patients and most of them described it as 
double vision for distant objects and on looking to either side. Visual 
obscurations was noted in 23 (57%) of patients in our study.  Similar incidence 
was noted in various other studies between 57-72%.  (Wall and George 1991, 
Radhakrishna 1993). 
Intracranial noises, describing as ringing and whooshing sounds, were 
heard in 15 (37%) of patients. Studies  by Wall and George noted higher 
prevalence (60%)  of intra cranial noises.  
Clinical Signs  
Papilledema is almost a universal finding in IIH patients all patients had 
papilledema either unilateral or bilateral. Bilateral papilledema was noted in 28 
patients whereas right alone in 8 patients and left eye alone in 4 patients.  
Another marked feature is presence of asymmetry in fundus findings even in 
patients with bilateral papilledema.  
Visual Acuity -  24 patients had decreased visual acuity either unilaterally 
or bilaterally as measured by Snellen’s chart.  Best vision was 6/6 and worst 
visual acuity recorded was  5/60, in a patients who had subsequent detoriation 
of vision and had to be taken up for surgery. 13 of this patients were wearing 
correction glasses prior to onset of headache, for refractory errors.  None of 
them had earlier prescription to compare the previous visual acuity.  Only 11 
patients were detected newly to have decreased visual acuity.  Literature 
suggests that there is reduced central visual acuity and that too in 1/4th of 
Patents (Craig et al 2001).  
Associated Conditions  
3 Patients in our study population were pregnant one in 1st trimester 
and other 2 in second trimester.  One patient was diagnosed as IIH 1 year 
Period to conception and was on Acetazolamide.  She had increased intensity 
of headache, Acetazolamide dose was titrated upwards, and intermittent 
analgesics were given.  Her pregnancy and post partum period were 
uneventful many studies have failed to prove the association of pregnancy 
with IIH.  Two Patient were diagnosed as Nephrotic syndrome 10 and 13 years 
before and was given a course of steroids. Both of them have stopped steroids 
long ago. Another patient was known  asthmatic since childhood and was 
taking salbutamol and budesonide nebulisation along with oral and systemic 
corticosteroids intermittently. However there is no history of abrupt withdrawl 
of corticosteroids.  
  
Investigations   
Visual field defects - The most common field defect noted is 
enlargement of blind spot, and this finding correlated with those patients who 
had papilledema.  It is the most common visual field defect noted by Rowe and 
sarkies in 1998, Hung et al in 2003 and gallium and van tavern 2004.  Apart 
from blind spot enlargement one patient had arcuate scotoma. Field defects 
other than blind spot enlargement, like arcuate scotoma, and centrocecal 
scotoma, with temporal and altitudinal field defect were also noted by Wall et 
al in 1991. 
CSF pressures. 
CSF opening pressures were elevated in 26 patient (>250mm CSF) in our 
study.  CSF Rout was elevated in 28 patient.  13 patient who had normal CSF 
opening pressure had elevated CSF Rout with clinical picture typical of IIH.  
Only one patient had   both CSF opening and rout values normal, but his clinical 
features, MRI features strongly correlated with IIH and was started on 
Acetazolamide, following which there was improvement of clinical  symptoms.  
Gjerris et al found raised Rout in the initial phase in most patients with IIH.  
Calabrese et al found Rout was  increased in all Patients with IIH.  Increased 
Rout was found in 8 of 70 patients by Sklas et al and many of them were 
receiving medical treatment.  10 out of 12 patients with IIH were found to have 
higher than normal Rout values (Alback et al).  In a study by Ramesh et al  in 
our institute in 2011, showed 71% patient had raised Rout.  Combined use of 
CSF opening and Rout values has detected IIH in 43 out of 47 Patient.  10 out of 
14 patients having normal opening pressure, had raised Rout values.   
Imaging 
The most common imaging finding in MRI was empty sella, which was 
seen in 24 patient in our study (10 alone& others in combination), which was 
followed by perioptic nerve sheath widening seen in 20 patient.  4 patient had   
combination of both. Flattening of posterior globe was seen in 10 patient.  
Transverse sinus stenosis (left) was noted in 4 patients.  There was no 
thrombosis. Study by Friedman and Jacobson (2002) noted similar MRI 
changes, however perioptic nerve stealth widening and kinking of optic nerve 
was noted in majority of patient. 
Course  
All 40 patient enrolled in study were started on acetazolamide and six 
were also started on diuretics. One month after starting treatment 32 patient 
reported improvement in symptoms.  Headache and visual disturbances 
decreased.  6 Reported to have same degree of symptoms and 2 reported 
worsening of headache and visual disturbance.  All 8 were started on diuretics 
also and repeat LP was done in 2 of them. 
Patients were asked report at the end of 3 months.  34 Patient reported 
after 3 months.  28 Patients had recurring symptoms.   
Among 32 Patient who were symptom free at 1 month, 28 Patient reported 
and 22 had recurrence of symptoms.  Among 8 patients who were 
symptomatic at end of 1month, 6 reported and all of them had persistence of 
symptoms. 
Recurrence rate was high in our study 54% (22 Patient) recurrence rates 
were low in studies by corbet et al 1982 (8%) and shall et al 2008 (15%).  
However study by kesler et al had a recurrence rate of 38%. 
Among 22 Patients who had recurrence of symptoms around 17 patients had 
either discontinued drugs or had poor drug compliance. 
Surgery  
Surgery was done in 7 patient enrolled in our study, who had recurrence 
of symptoms at the end of three month treatment period. Worsening of vision 
was the indication for surgery in all the 7 patients.  All of them underwent 
lumbo peritoneal shunt.  Six patients had repeat LP done prior to surgery.  Post 
operative period was uneventful for 6 patients. One Patient developed 2 
episodes of  generalized tonic -  conic seizures on 5th post operative day and 
new onset varying of type of headache that aggravated on assuming erect 
posture. There was no focal neurological deficits or  meaningeal signs.  Post 
Operative MRI showed T2 and FLAIR hyper intensities in left posterior cortex 
with gyral enhancement and pachymeningeal enhancement in contrast, 
suggestive of intracranial hypotension. Patient improved with bed rest and 
steroids.    
Clinical characteristics 
 All the seven were females. 3 were in 26-30yrs, 2 in 36-40 yrs age group, 
others were 22 and 41 yrs old. 1 patient was overweight and the rest were 
obese. All had presenting visual acuity of 6/60 or lower and visual acuity was 
reduced bilaterally. None of them had associated conditions like pregnancy 
and none of them had taken any other medications previously. 
Symptom analysis 
PT. NO HEADACHE DIPLOPIA VISION DIST. TINNITUS 
1 + + + - 
2 + - - - 
3 + + + + 
4 + + + - 
5 + + + - 
6 + + + - 
7 + - - + 
TOTAL 7 5 5 2 
 
 All patients had complaints of headache at presentation, diplopia and 
vision disturbances were present in 5 patients and tinnitus was present in only 
2 of them. Headache was the most prominent complaint, followed by diplopia 
and vision disturbances. 
Signs  
PT. NO PAPILLEDEMA VISUAL ACUITY DEFECT LATERAL RECTUS PALSY 
 U/L B/L U/L B/L U/L B/L NIL 
1 - + - + + - - 
2 + - - + - - + 
3 - + - + + - - 
4 - + - + + - - 
5 - + - + - + - 
6 - + - + - + - 
7 + - - + - - + 
TOTAL 2 5  7 3 2 2 
 
Papilledema was present in all patients, bilaterally in 5 and unilaterally in 
2 and all patient had a decreased visual acuity of 6/60 or lesser bilaterally. 
Presence of decreased visual acuity at the early in the course of illness may 
predict early surgical intervention in those patients.  
INVESTIGATIONS 
All seven had abnormalities in MRI, which are consistent with diagnosis of IIH 
PT.NO Empty sella Optic nerve 
sheath 
widening and 
kinking of 
optic nerve 
Thining of 
post. Globe 
Transverse 
sinus stenosis 
1 - + - - 
2 + + + + 
3 - + + - 
4 + + + - 
5 + + - + 
6 - + - - 
7 + + - - 
Total 4 7 3 2 
 
 All the 7 patients had perioptic nerve sheath widening and kinking of 
optic nerve, while empty sella was present in 4 and transverse sinus stenosis in 
only 2 patients. Empty sella and Optic nerve sheath widening and kinking of 
optic nerve together was found in 4 patients and all the findings in only 2 
patients. 
CSF Pressure studies 
PT.NO OPENING PRESSURE(mm CSF) CSF Rout (mmHg/ml/min) 
1 35 6.6 
2 36 10.9 
3 65 17 
4 80 36 
5 45 8.1 
6 37 5.8 
7 37 16.1 
 
 All 7 patients had elevated opening pressure ranging from 35 to 80 mm 
CSF. However CSF Rout was elevated only in 4 patients and 3 had normal 
opening pressure. 
 Among the parameters assessed high BMI in the range of obesity, 
decreased visual acuity early in course of illness and presence of peri optic 
nerve sheath widening and kinking of optic nerve in MRI were more associated 
with need for surgical intervention.  
 
 
CONCLUSION 
In our study we analysed the demographic features, clinical presentation, 
investigations and outcome of IIH patients, following conclusions were 
observed 
 Majority of our patients were in 2nd – 3rd decade. 
 There was high female preponderance in our study 
 Obesity was the most common risk factor. 
 Headache is the universal presenting symptom in all patients, followed 
by diplopia and visual disturbances 
 All of them had papilledema as a predominant finding, followed by 
lateral rectus palsy but no other focal neurologic deficits 
 Typical imaging findings of IIH were present in majority of patients 
 Three fourths of our patients had elevated CSF opening pressure 
 Significant number of patients with normal opening pressure  had raised 
CSF Rout and classical symptoms and imaging findings of IIH which 
helped in diagnosis 
 One fourth of the patient improved with medications alone and 
remained symptom free by three months 
 Three fourths of the patients had recurrence of symptoms, which was 
managed with increased dosage of drugs and half of them showed 
improvement in symptoms 
 Eighteen percent of the patients underwent surgery for recurrence of 
symptoms while remaining were managed conservatively 
 Among the parameters assessed, high BMI in the range of obesity, 
decreased visual acuity early in course of illness and presence of peri 
optic nerve sheath widening  in MRI were more associated with need for 
surgical intervention . 
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ABBREVATIONS 
IIH      - Idiopathic Intracranial Hypertension 
ICP    - Intracranial pressure 
CSF    - Cerebro Spinal Fluid 
BMI     - Body Mass Index 
R out   - Resistance to outflow 
NSAIDS    - Non steroidal anti inflammatory drugs 
LP        -Lumbar puncture 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 PROFORMA 
 
Patient Number:  
Age:                                                        Sex                                              
HISTORY  
Symptoms:   Headaches                       
                        Visual loss  
                        Transient visual obscurations  
                        Double vision  
                        Nausea & vomiting  
                        Others  
  
Duration of symptoms : 
  
Associations:     Obesity or recent weight gain  
                           Medical conditions                                                 
                           Pregnancy  
                           Medication or drug use                                        
  
Examination:  
  
Visual acuity:    Initial             R                     L                                           
 
Ocular motility:                        R                     L  
 
Pupil reactions:                         R                     L  
 
Fundus examination:        
               Optic discs                 R                     L  
 
               Rest of fundus            R                     L   
 
Neurological examination:   HMF 
                                             
                                              CN 
                                              
                                             SMS 
                                       SENSORY 
                                              EPS 
                                             PN S 
  
 
 
 
INVESTIGATIONS:   Hemogram 
                          RFT 
                          LFT 
 
VISUAL  FIELD CHARTING  R  L 
  
NEUROIMAGING:               CT SCAN                                                 
 
                     MRI 
  
LUMBAR PUNCTURE:         Opening pressure                                
 
                                     R out 
 
                                 CSF composition    PROTEIN 
                                                                   SUGAR 
                                                                    CELLS 
     
 
 
 
 
MANAGEMENT:  
 
  
Weight loss: 
                            
Medical:              acetazolamide                  Steroids    
 
  
Surgical:              ONSF                      Lumbar peritoneal shunt        Multiple LP’S      
 
 
 
 
 
 
 
 
                                     PATIENT CONSENT FORM 
 
Study Details: “ANALYSIS OF CLINICAL PROFILE, LABORATORY 
INVESTIGATIONS AND MANAGEMENT MODALITIES OF 
PATIENTS WITH IDIOPATHIC INTRACRANIAL 
HYPERTENSION” 
 
Study Centre: Rajiv Gandhi Government General Hospital, Madras Medical 
College, Chennai- 03 
 
Patient may check () these boxes: 
 
 I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask questions and all my questions and doubts 
have been answered to my complete satisfaction. 
 
 I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal rights 
being affected. 
 
 I understand that the sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authourities will not 
need my permission to look at my health records, both in respect of current study 
and any future research that may be conducted in relation to it, even if I 
withdraw from the study I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study. 
 
 I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my health 
or well being or any unexpected or unusual symptoms. 
 
 I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, microbiological, 
radiological tests and lumbar puncture procedures, if deemed necessary.  
I hereby consent to participate in the study. 
 
Signature/Thumb impression:     Place: 
Patient name and address:      Date: 
 
Signature/Thumb impression:     Place: 
Study investigator’s name:      Date: 
 
 
INFORMATION SHEET 
 
 
 We are conducting a study of “ANALYSIS OF CLINICAL PROFILE, 
LABORATORY INVESTIGATIONS AND MANAGEMENT MODALITIES 
OF PATIENTS WITH IDIOPATHIC INTRACRANIAL 
HYPERTENSION” attending the Neurology services of Rajiv Gandhi 
Government General Hospital, Chennai. 
 
 The purpose of the study is to study the clinical profile of patients with 
idiopathic intracranial hypertension 
 
 The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 
 Taking part in the study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 
 The results of the study may be intimated to you at the end of the study period 
or during the study if anything is found abnormal which may aid in the 
management or treatment 
 
 
 
 
 
Signature of the investigator    Signature of the participant 
Date:         
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